Penn Medicine Provider
Medical Oncology
Lin Mei, MD
4.8
(177)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Penn Presbyterian
View 1 additional location
Make an appointmentCall 215-615-5858

About me

  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Beijing Medical University
  • Residency: University at Buffalo, Jacobs School of Medicine and Biomedical Sciences
  • Fellowship: Virginia Commonwealth University

What my patients think about me

Average Rating
4.8

177 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
hes wonderful
May 2025
5.0
5.0
dr. mei always listens to my concerns and we set up a plan going forward
April 2025
5.0
5.0
very caring and experienced physician
April 2025
4.0
4.0
it was informative for me

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Mei is a Penn Medicine physician.

Qualifications and experience

My research

Koga S, Mei L. Perioperative Durvalumab in Bladder Cancer , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, California : 2025

Koga S, Mei L. Perioperative Durvalumab in Bladder Cancer , N Engl J Med, 392: 2025,618-619

Adam Barsouk, Omar Elghawy, Austin Yang, Jonathan H. Sussman, Ronac Mamtani and Lin Mei Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment , Cancers, 16(19): 2024,3338

Wei Du, Lin Mei A case report of pegcetacoplan use for a pregnant woman with paroxysmal nocturnal hemoglobinuria , Res Pract Thromb Haemost, 8(4): 2024,102435

Du W, Estalilla OC, Jelic TM, Hayes JD, Tobin EC, Mei L. Bone marrow involvement by breast implant-associated anaplastic large cell lymphoma. , Br J Haematol , 198(6): 2022,938

Du W, Sirbu C, Lucas BD Jr, Jubelirer SJ, Khalid A, Mei L A Retrospective Study of Brain Metastases from Solid Malignancies: The Effect of Immune Checkpoint Inhibitors. , Front Oncol , 27: 2021,11:667847

Williams CM, Du W, Mangano WE, Mei L. Mediastinal Low-Grade Fibromyxoid Sarcoma with FUS-CREB3L2 Gene fusion. , Cureus , 13(6): 2021,e15606.

Mei L, Zheng YM, Song TY, Yadav VR, Joseph LC, Truong L, Kandhi S, Barroso MM, Takeshima H, Judson MA, Wang YX. Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF-κB/cyclin D1 pathway. , Nat Commun , 11(1): 2020,3527

Khurana A, Mei L, Faber AC, Smith SC, Boikos SA. Paraganglioma in Carney-Stratakis Syndrome , Horm Metab Res, 51(7): 2019,437-442

Mei L, Khurana A, Al-Juhaishi T, Farber A, Celi F, Smith S, Boikos S. Prognostic factors of malignant pheochromocytoma and paraganglioma: A combined SEER and TCGA databases review. , Horm Metab Res , 51(7): 2019,451-457